Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

TGXIME - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/TGXIME

Approved

STANDARD

TGXIME

Scott-Edil Advance Research Laboratories & Education Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 990e834a378e3681
Company: Scott-Edil Advance Research Laboratories & Education Limited
Type: Standard

Approval Details

Approval Id: 990e834a378e3681
Drug Approval Philippines Name: TGXIME
Product Name: TGXIME
Registration Number: DRP-5121-14
Brand Name: TGXIME
Generic Name: Cefixime (as trihydrate)
Dosage Form: Film-Coated Tablet
Dosage Strength: 200 mg
Manufacturer: Scott-Edil Advance Research Laboratories & Education Limited
Importer: Pharmakon Biotec Inc
Distributor: TGIF Pharmaceutical Trading Inc.
Issuance Date: 24 April 2024
Expiry Date: 14 October 2028
Pharmacologic Category: Antibacterial (Third Generation Cepahlosporin)
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

990e834a378e3681

Type

Standard

Back to Philippines FDA Approvals